TrialIn vivo (Athens, Greece)

Oral 5-aminolevulinic Acid for Patients With Localized Prostate Cancer Undergoing Low-dose-rate Brachytherapy: AMBER Trial.

Makito Miyake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.